Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Pregenerate Inc. logo — Revolutionizing osteoarthritis treatment

Pregenerate Inc.

Revolutionizing osteoarthritis treatment

Founded 2019 Austria Austria 6 employees Convertible Note Total: $130.00K Biotechnology, Life Sciences +1

General Information

Company Name Pregenerate Inc.
Founded Year 2019
Location Austria Austria
Employees 6
Industries Biotechnology, Life Sciences, Medical Devices
Funding Stage Convertible Note
Social

BounceWatch is an independent company data service, not affiliated with Pregenerate Inc.. To contact Pregenerate Inc., visit pregenerate.net.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Pregenerate Inc. compare?

A PDF of Pregenerate Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Pregenerate Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Pregenerate Inc.

Pregenerate is a biotechnology startup focused on revolutionizing osteoarthritis treatment. Founded in 2019 and based in Austria, the company aims to replace expensive and inefficient animal testing in medical and pharmaceutical research. Pregenerate's products and services utilize scaleable organ-on-a-chip models to advance pharmaceutical research for arthritis treatments. By employing human cells in their model, the company helps pharmaceutical companies save billions of dollars and improve the success rates of their drugs to market. In June 2022, Pregenerate secured a Convertible Note investment from SOSV, signaling investor confidence in the company's innovative approach to addressing the global degenerative joint disease, osteoarthritis. This technology not only has the potential to impact the aging human population but also sport horses and companion animals, and in the long run, it could enable personalized treatment for arthritis patients, emphasizing the company's potential for growth and impact in the Life Sciences and Medical Devices industries.

Business keywords: medical research, pharmaceutical, organ-on-a-chip model, arthritis treatments, animal testing alternative, degenerative joint disease, osteoarthritis, drug development, patient stratification, biomedical technology

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Convertible Note Undisclosed 1
SOSV
SOSV
07 Jun 2022
Seed Round Undisclosed 1
SOSV
SOSV
31 May 2021
Seed Round Undisclosed 2
SOSV
SOSV, RebelBio
06 Oct 2020
Pre Seed Round $130.00K 1
SOSV
SOSV
08 Jan 2019

Pregenerate Inc. Alternatives & Competitors

View All Alternatives
Pregenerate Inc. vs
Emulate, Inc.
Emulate, Inc. United States

Our Organ-on-a-Chip technology provides a high-fidelity window into the inner workings of human biol...

Series F
71 employees
Biotechnology, Health Care
Pregenerate Inc. vs
CN Bio
CN Bio United Kingdom

Generate human-specific efficacy and safety data with PhysioMimix® microphysiological systems.

Series B
59 employees
Biopharma, Biotechnology
Pregenerate Inc. vs
Qureator
Qureator United States

Create to Cure

Series A
22 employees
Biotechnology, Life Sciences
View all alternatives

FAQ About Pregenerate Inc.

Revolutionizing osteoarthritis treatment
Pregenerate Inc. was founded in 2019.
Pregenerate Inc. is headquartered in Austria.
Pregenerate Inc. operates in Biotechnology, Life Sciences and Medical Devices. Its work centres on medical research, pharmaceutical, organ-on-a-chip model and arthritis treatments.
Pregenerate Inc. has approximately 6 employees.
Pregenerate Inc. has completed 4 funding rounds, raising a total of $130.00K. The latest funding stage is Convertible Note.
Top alternatives and competitors to Pregenerate Inc. include Emulate, Inc., CN Bio, Qureator , InVivo Biosystems, Finnadvance. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Pregenerate Inc. and Emulate, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Pregenerate Inc., https://bouncewatch.com/company/pregenerate, updated 11 May 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout